Endotheliopathy and Platelet Dysfunction as Hallmarks of Fatal Lassa Fever
Lucy E. Horton
1, Robert W. Cross
1, Jessica N. Hartnett, Emily J. Engel, Saori Sakabe, Augustine Goba, Mambu Momoh, John Demby Sandi, Thomas W. Geisbert, Robert F. Garry, John S. Schieffelin, Donald S. Grant, and Brian M. Sullivan
Author affiliations: The Scripps Research Institute, La Jolla, California, USA (L.E. Horton, S. Sakabe, B.M. Sullivan); University of Texas Medical Brach, Galveston, Texas, USA (R.W. Cross, T.W. Geisbert); Tulane University School of Medicine, New Orleans, Louisiana, USA (J.N. Hartnett, E.J. Engel, R.F. Garry, J.S. Schieffelin); Kenema Government Hospital, Kenema, Sierra Leone (A. Goba, M. Momoh, J.D. Sandi, D.S. Grant); Ministry of Health and Sanitation, Freetown, Sierra Leone (A. Goba, M. Momoh, J.D. Sandi); Eastern Polytechnic Institute, Kenema (M. Momoh, D.S. Grant); Njala University, Moyamba, Sierra Leone (J.D. Sandi); University of Sierra Leone, Freetown (D.S. Grant)
Main Article
Figure 4
Figure 4. Hepatocyte growth factor plasma levels in patients with acute LF and liver function tests in acute LF cases, Sierra Leone, 2015–2018. A) HGF was positively correlated with total bilirubin (n = 23), alkaline phosphatase (n = 26), AST (n = 26), and ALT (n = 27). B) HGF levels in acute LF patients were statistically significantly higher (***p = 0.0005) in patients who died (n = 14) than those who survived (n = 7), and a statistically significant positive correlation between HGF and LASV antigen was observed in LF patients (n = 22). Dashed lines and gray shading indicate limits of detection. ALT, alanine aminotransferase; AST, aspartate aminotransferase; D, died; HGF, hepatocyte growth factor; LF, Lassa fever; LASV-Ag, Lassa fever virus antigen; S, survived.
Main Article
Page created: September 09, 2020
Page updated: October 17, 2020
Page reviewed: October 17, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.